Insider Transactions in Q4 2023 at Walgreens Boots Alliance, Inc. (WBA)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 10
2023
|
Richard P. Gates SVP, Chief Pharmacy Officer |
SELL
Open market or private sale
|
Direct |
1,000
-1.33%
|
$20,000
$20.45 P/Share
|
|
Nov 01
2023
|
Timothy C Wentworth Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
562,324
+50.0%
|
-
|
|
Nov 01
2023
|
Neal J. Sample EVP, Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
193,767
+34.74%
|
-
|
|
Nov 01
2023
|
Holly May EVP, Global Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,091
-1.06%
|
$85,911
$21.08 P/Share
|
|
Nov 01
2023
|
Holly May EVP, Global Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
118,557
+38.06%
|
-
|
|
Nov 01
2023
|
Manmohan Mahajan EVP and Global CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,430
-1.36%
|
$51,030
$21.08 P/Share
|
|
Nov 01
2023
|
Manmohan Mahajan EVP and Global CFO |
BUY
Grant, award, or other acquisition
|
Direct |
35,145
+36.92%
|
-
|
|
Nov 01
2023
|
Danielle Gray EVP and Global CLO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,758
-1.11%
|
$99,918
$21.08 P/Share
|
|
Nov 01
2023
|
Danielle Gray EVP and Global CLO |
BUY
Grant, award, or other acquisition
|
Direct |
134,021
+38.39%
|
-
|
|
Nov 01
2023
|
Todd Heckman SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
839
-0.99%
|
$17,619
$21.08 P/Share
|
|
Nov 01
2023
|
Todd Heckman SVP, Global Controller and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
16,401
+36.44%
|
-
|
|
Nov 01
2023
|
John Patrick Driscoll EVP, Pres. U.S. Healthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
5,725
-2.06%
|
$120,225
$21.08 P/Share
|
|
Nov 01
2023
|
John Patrick Driscoll EVP, Pres. U.S. Healthcare |
BUY
Grant, award, or other acquisition
|
Direct |
217,901
+43.95%
|
-
|
|
Nov 01
2023
|
Richard P. Gates SVP, Chief Pharmacy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,378
-0.6%
|
$28,938
$21.08 P/Share
|
|
Nov 01
2023
|
Richard P. Gates SVP, Chief Pharmacy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,860
+38.05%
|
-
|
|
Nov 01
2023
|
Kevin M. Ban EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,458
-0.99%
|
$72,618
$21.08 P/Share
|
|
Nov 01
2023
|
Kevin M. Ban EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
84,349
+41.81%
|
-
|
|
Nov 01
2023
|
Tracey D Brown EVP, Pres., Walgreens Retail |
SELL
Payment of exercise price or tax liability
|
Direct |
4,037
-1.3%
|
$84,777
$21.08 P/Share
|
|
Nov 01
2023
|
Tracey D Brown EVP, Pres., Walgreens Retail |
BUY
Grant, award, or other acquisition
|
Direct |
117,151
+42.84%
|
-
|
|
Nov 01
2023
|
Thomas E Polen Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,696
+50.0%
|
-
|
|
Nov 01
2023
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,694
+38.93%
|
-
|
|
Nov 01
2023
|
Bryan C Hanson Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,694
+50.0%
|
-
|
|
Nov 01
2023
|
Ornella Barra Chief Operating Officer, Int'l |
SELL
Payment of exercise price or tax liability
|
Direct |
6,235
-0.99%
|
$130,935
$21.08 P/Share
|
|
Nov 01
2023
|
Ornella Barra Chief Operating Officer, Int'l |
BUY
Grant, award, or other acquisition
|
Direct |
257,732
+29.07%
|
-
|
|
Oct 25
2023
|
Richard P. Gates SVP, Chief Pharmacy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,189
-3.88%
|
$24,969
$21.37 P/Share
|
|
Oct 25
2023
|
Richard P. Gates SVP, Chief Pharmacy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,057
+11.69%
|
-
|
|
Oct 25
2023
|
Manmohan Mahajan EVP and Global CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,189
-4.56%
|
$24,969
$21.37 P/Share
|
|
Oct 25
2023
|
Manmohan Mahajan EVP and Global CFO |
BUY
Grant, award, or other acquisition
|
Direct |
4,057
+13.46%
|
-
|
|
Oct 25
2023
|
Todd Heckman SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
849
-6.5%
|
$17,829
$21.37 P/Share
|
|
Oct 25
2023
|
Todd Heckman SVP, Global Controller and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
2,898
+18.16%
|
-
|
|
Oct 25
2023
|
Kevin M. Ban EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,933
-5.53%
|
$40,593
$21.37 P/Share
|
|
Oct 25
2023
|
Kevin M. Ban EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,796
+14.22%
|
-
|
|
Oct 25
2023
|
Ornella Barra Chief Operating Officer, Int'l |
SELL
Payment of exercise price or tax liability
|
Direct |
7,089
-1.87%
|
$148,869
$21.37 P/Share
|
|
Oct 25
2023
|
Ornella Barra Chief Operating Officer, Int'l |
BUY
Grant, award, or other acquisition
|
Direct |
52,167
+12.12%
|
-
|
|
Oct 25
2023
|
Stefano Pessina Executive Chairman of Board |
BUY
Grant, award, or other acquisition
|
Direct |
207,039
+16.38%
|
-
|